Expands requirements for health insurance carriers concerning prostate cancer screening and requires coverage be provided without cost sharing.

The age restriction on no-cost-sharing coverage was removed. The original bill limited free prostate cancer screening to men between 40 and 75 years of age; the committee struck this limitation, meaning the no-cost-sharing requirement would apply regardless of age.

A new requirement mandates that prostate cancer screening be provided in accordance with the latest nationally recognized clinical practice guidelines. This ties coverage to current medical evidence rather than requiring coverage for all screening methods unconditionally.

A new definition of 'nationally recognized clinical practice guidelines' was added, specifying they must be evidence-based, developed by independent organizations or medical professional societies, use transparent methodology and reporting, have a conflict of interest policy, and be informed by systematic review of evidence with assessment of benefits and risks.

New provisions in every section address applicability to high-deductible health plans (HDHPs), medical savings accounts under IRC Section 220, health savings accounts under IRC Section 223, and catastrophic plans as defined in 45 C.F.R. s.156.155. The requirements apply to these plan types only to the maximum extent permitted by federal law, with specific carve-outs to avoid disqualifying HSA or MSA tax deductions.

Five additional senators (Diegnan, Space, McKeon, Steinhardt, and McKnight) were added as co-sponsors, indicating broader legislative support for the bill after committee review.

The effective date was modified. While most of the bill still takes effect 90 days after enactment, a new exception provides that Section 7 (covering individual health plans under P.L.1992, c.162) shall take effect on January 1, 2027 instead.